You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com | |
Most viewed
- 1. FDA approves darolutamide for metastatic castration-sensitive prostate cancer
- 2. ESPN's Jay Harris Diagnosed With Prostate Cancer
- 3. It's my goal to live to 100 – and it's not just diet and exercise that will help me achieve it
- 4. Food-derived compounds targeting ferroptosis for cancer therapy: from effects to mechanisms
- 5. Why is there such a generational divide in views on sex and gender in Britain? | Susanna Rustin
- 6. Private Astronaut Mission Includes Research to Open Space to Astronauts With Diabetes and Enable Early Cancer Detection
- 7. Efficacy and safety of Eribulin-based chemotherapy in HER2 negative advanced breast cancer patients: a real-world study
- 8. Prediction of metastatic risk of renal clear cell carcinoma based on CT radiomics analysis
- 9. Case Report: Liver and bladder metastasis in a patient with HR-positive, HER2-low breast cancer
- 10. Avenzo begins Phase I/II trial of CDK4 selective inhibitor for breast cancer
Last updated at 21:10 GMT
Hot News Makers
Health/Pharma Companies
- 56616.32
- 39786.58
- 17428.03
- 7565.97
- 6798.38
- 5453.25
- 5424.24
- 5311.24
- 3988.35
- 3824.33
Drugs, Treatments, Trials
- 21623.83
- 8488.48
- 7089.49
- 6794.93
- 5949.00
- 4777.49
- 3072.73
- 2717.25
- 2594.68
- 2087.01
Last updated at 20:10 GMT
